Caspase-3 cleaves XIAP in a positive feedback loop to sensitize melanoma cells to TRAIL-induced apoptosis

M Hörnle1, N Peters, B Thayaparasingham

  • 1Institute of Cell Biology and Immunology, University of Stuttgart, Stuttgart, Baden-Württemberg, Germany.

Oncogene
|September 22, 2010
PubMed

Insights

Ultraviolet (UV) B light combined with tumor necrosis factor related apoptosis inducing ligand (TRAIL) therapy sensitizes melanoma cells. UVB triggers caspase-3 to cleave X-linked inhibitor of apoptosis protein (XIAP), enhancing TRAIL-induced apoptosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Dermatology

Background:

  • Melanoma metastasis is challenging due to chemoresistance and radioresistance.
  • Combinational treatments involving death ligands are crucial for effective melanoma therapy.
  • Melanoma cell resistance to tumor necrosis factor related apoptosis inducing ligand (TRAIL) is often mediated by X-linked inhibitor of apoptosis protein (XIAP).

Purpose of the Study:

  • To elucidate the molecular mechanism by which ultraviolet (UV) B irradiation sensitizes melanoma cells to TRAIL.
  • To identify the specific caspase responsible for X-linked inhibitor of apoptosis protein (XIAP) cleavage after UVB treatment.
  • To explore the broader implications of this mechanism in melanoma treatment.

Main Methods:

  • Treatment of melanoma cell lines with TRAIL and sub-lethal ultraviolet (UV) B irradiation.
  • Assessment of X-linked inhibitor of apoptosis protein (XIAP) levels and caspase-3 processing.
  • Utilization of caspase inhibitors and small interfering RNA (siRNA) for knockdown studies.
  • Analysis of mitochondrial outer membrane permeabilization and Smac release.

Main Results:

  • Co-irradiation with ultraviolet (UV) B caused X-linked inhibitor of apoptosis protein (XIAP) depletion, synergistically sensitizing melanoma cells to tumor necrosis factor related apoptosis inducing ligand (TRAIL).
  • X-linked inhibitor of apoptosis protein (XIAP) depletion requires initial caspase-mediated cleavage, promoting its proteasomal degradation.
  • Caspase-3 was identified as the primary caspase responsible for cleaving X-linked inhibitor of apoptosis protein (XIAP) after UVB treatment, leading to its activation and subsequent apoptosis.
  • Ultraviolet (UV) B and TRAIL co-treatment accelerated mitochondrial outer membrane permeabilization, releasing Smac and other XIAP antagonists.

Conclusions:

  • Ultraviolet (UV) B irradiation sensitizes melanoma cells to TRAIL by inducing caspase-3-mediated cleavage and degradation of X-linked inhibitor of apoptosis protein (XIAP).
  • This mechanism involves caspase-3 activation, accelerated mitochondrial outer membrane permeabilization, and release of XIAP-antagonizing factors.
  • The discovered molecular mechanism of X-linked inhibitor of apoptosis protein (XIAP) cleavage has potential implications for other chemo-sensitization strategies in melanoma.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...